Thelopharm, N.V.
Thelopharm was a pharmaceutical company affiliated with Sangostop. Opekta did business with Sangostop.
Addresss: Looiersgracht 25, Amsterdam.[1]
Thelopharm was a pharmaceutical company affiliated with Sangostop[2] and the brothers Max and Benno Brahn.[3] Max Brahn was director of Thelopharm.[4] On 20 March 1936, an annual meeting took place in the building of the Hollandsche Bank Unie, immediately following that of Sangostop.[5]
The company was also affiliated with Brocades Stheeman. It engaged in the manufacturing and trading of pharmaceutical and chemical products. Max Brahn became a commissioner and vice-chairman of the Supervisory Board of Thelopharm in November 1939.[6]
In 1943 the registered capital amounted to one hundred thousand guilders, of which twenty-four thousand had been issued.[7] In 1945, Thelopharm owned a Canadian patent on an insulin application invented by Benno Brahn.[8]
Footnotes
- ^ Naamlijst voor den interlocalen telefoondienst, z.p.: Hoofdbestuur der P.T.T., januari 1941, p. 271.
- ^ Sangostop was een farmaceutisch bedrijf waarmee Opekta zaken deed.
- ^ Zakenrelatie van Otto Frank. Otto Frank heeft Brahns telefoonnummer in zijn agenda's genoteerd van 1937 en 1946 t/m 1952. Anne Frank Stichting, Anne Frank Collectie, Otto Frank Archief, reg. codes OFA_001 en 003 t/m 009.
- ^ Stadsarchief Amsterdam, Dienst Bevolkingsregister, Archiefkaarten (toegangsnummer 30238): Archiefkaart M. Brahn.
- ^ “Vergaderingen”, Algemeen Handelsblad, 20 maart 1936 (ochtendeditie).
- ^ N.E. Onnes Rost wordt voorzitter. “Handelsregister. Wijzigingen November 1939”, Pharmaceutisch Weekblad. Orgaan van de Nederlandsche Maatschappij ter bevordering van de Pharmacie, 6 januari 1940.
- ^ Deutsche Zeitung in den Niederlanden, 19 oktober 1943, p. 6.
- ^ Canadian Intellectual Property Office, Patent 425759 Summary.